XML 74 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities:      
Net loss $ (274,158) $ (220,872) $ (123,603)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation, amortization and impairment charges 4,136 8,307 4,614
Stock-based compensation 35,421 20,341 7,675
Deferred executive compensation expense 963 2,810 1,719
Revaluation of warrant liability   15,924 46,715
Increase (decrease) from:      
Accounts receivable (1,305)    
Inventory (413)    
Other current assets (2,113) (4,714) 228
Other assets (2,714)    
Accounts payable 2,478 2,664 2,394
Accrued compensation and benefits 913 10,656 82
Accrued product development expenses 2,679 2,113 3,759
Other accrued expenses 1,340 4,669 1,271
Other liabilities 14,834 5,714 1,660
Deferred revenue 10 (230) 999
Deferred executive compensation paid (3,953) (1,063) (775)
Net cash used in operating activities (221,882) (153,681) (53,262)
Cash flows from investing activities:      
Acquisitions of marketable securities   (89,554)  
Proceeds from maturities of marketable securities 45,000 44,500  
Change in restricted cash (10,319) (289)  
Investment in property and equipment (8,543) (4,424) (1,452)
Investment in intangible assets   (633) (671)
Net cash provided by (used in) investing activities 26,138 (50,400) (2,123)
Cash flows from financing activities:      
Proceeds from long-term borrowings     4,375
Repayment of long-term borrowings (2,100) (1,400) (1,400)
Principal payments under capital lease obligations (15) (54) (66)
Proceeds from issuance of common stock, net of issuance costs 310,037   243,058
Reimbursements of amounts related to facility lease obligation 2,741    
Proceeds from issuance of common stock pursuant to warrants   12,483 8,080
Proceeds from issuance of common stock pursuant to stock option and purchase plans 6,284 10,511 4,791
Payment of tax withholding obligations related to stock compensation (3,363) (4,336) (827)
Net cash provided by financing activities 313,584 17,204 258,011
Effect of exchange rates on cash (40)    
Net increase (decrease) in cash and cash equivalents 117,800 (186,877) 202,626
Cash and cash equivalents, beginning of year 119,379 306,256 103,630
Cash and cash equivalents, end of year 237,179 119,379 306,256
Supplemental disclosures:      
Interest paid 153 206 230
Income taxes paid 17    
Capitalization of construction-in-progress related to facility lease obligation 96,671    
Non-cash transaction - property and equipment included in accounts payable or accruals $ 738 $ 579 $ 911